Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-14

Clinical Trial Update: A Study in Participants With Diabetic Peripheral Neuropathic Pain in China [Phase 3]

View source ↗

Summary

A Phase 3 study in China evaluating a treatment for painful diabetic neuropathy sponsored by Eli Lilly and Company has completed and posted results in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetic Neuropathy, Painful | Phase 3 | Status: COMPLETED | Results posted: 2014-07-14